KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,271 | -52.6% | 10,148 | -61.6% | 0.00% | – |
| Q2 2023 | $371,980 | +158.3% | 26,419 | +136.0% | 0.00% | – |
| Q3 2022 | $144,000 | -63.6% | 11,194 | -72.6% | 0.00% | – |
| Q2 2022 | $396,000 | -45.3% | 40,859 | -43.8% | 0.00% | – |
| Q1 2022 | $724,000 | -19.7% | 72,731 | -5.2% | 0.00% | – |
| Q4 2021 | $902,000 | +127.8% | 76,700 | +120.3% | 0.00% | – |
| Q3 2021 | $396,000 | +144.4% | 34,821 | +228.5% | 0.00% | – |
| Q3 2020 | $162,000 | – | 10,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |